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 Abstract 
Diffuse axonal injury (DAI) is an important cause of morbidity in patients with traumatic 
brain injury (TBI). There is a lack of a simple and reliable technique to early identify patients 
with DAI and to prognosticate long-term outcome in this patient group.  
In the present study we examined acute serum concentrations of NFL (neurofilament light) in 
nine patients with severe TBI and DAI using a novel ultrasensitive Single molecule array 
(Simoa) assay. The relationships between the NFL concentrations and MRI in the acute stage 
as well as clinical outcome and MR-DTI parameters at 12 months were analysed. 
We found that the mean NFL concentrations among the patients displayed a 30-fold increase 
compared to the controls and that the NFL completely discriminated between the patients and 
the controls. We also found a relation between the increased concentration of NFL and the 
MR-DTI parameters.  
Although the number of patients in the study is small our results indicate that NFL may be a 
useful blood biomarker of TBI and that serum NFL might be an indicator of the severity of 
DAI. 
 
  
 
 
 
 
 
 
 
 
 Introduction 
Diffuse axonal injury (DAI), caused by stretching and shearing forces of the white matter 
axonal fibers in the brain, is the primary neuropathological change in patients with traumatic 
brain injury (TBI).1 The rapid inertial forces of acceleration and deceleration initiate a 
progressive process that leads to axonal failure and disconnection.2,3 DAI is a common feature 
of severe TBI but is also considered to be important in mild TBI and might be involved in the 
development of post-concussive syndrome (PCS) with lasting and commonly disabling effects 
including headache, concentration difficulties, insomnia, mood disturbances, and dizziness.4 
There is a lack of reliable techniques to identify and quantify DAI in TBI patients. 
Conventional neuroimaging such as computerized tomography (CT) is considered inadequate 
for the evaluation of DAI, and standard magnetic resonance imaging (MRI) techniques lack 
sensitivity and are thus criticized for underestimating the extent of injury.5 Magnetic 
resonance diffusion tensor imaging (MR-DTI) is increasingly used to detect DAI. DTI can 
indirectly evaluate the integrity of white matter tracts by measuring water diffusion, its 
directionality in three dimensions, and the diffusion anisotropy.6 A large number of studies 
have shown that DTI can be used to detect alterations in the white matter ultrastructure after 
TBI (for a recent review see Studerus-Germann et al.7). However, MR-DTI is still mainly 
used in research studies and not in clinical routine. Further, it is not known how sensitive MR-
DTI is to detect DAI in mild TBI cases, and the technique has not been cross-validated 
against post-mortem histology measures of axonal injury in humans. The analysis often needs 
time-consuming manual calculations, different hospitals use different methods for analysis 
and it is difficult to compare DTI parameters between research groups. 
The search for a useful biomarker has been an alternative way to try to diagnose and quantify 
DAI. An ideal blood biomarker should have increased serum levels in the acute stage related 
to TBI-induced DAI and persistent brain dysfunction. Further, since DAI by definition 
 involves damage to the long myelinated white-matter axons, neuronal proteins enriched in 
these structures are top candidates as fluid biomarkers. A number of proteins have been 
evaluated as candidate blood biomarkers for TBI but none has so far proved to be of 
prognostic value regarding DAI. 
NFL (neurofilament light) protein is an important structural protein of the axonal 
cytoskeleton.8 Upon axonal injury, NFL leaks from disrupted axons into the brain interstitial 
fluid, cerebrospinal fluid and blood. In the present prospective longitudinal study we have 
examined NFL as a potential blood-based biomarker for DAI using an ultrasensitive Single 
molecule array (Simoa) assay in a cohort of patients with DAI and compared it to the 12-
month outcome and MR-DTI parameters. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Methods 
This study was approved by the Regional Ethical Review Board at the University of 
Gothenburg, and informed consent was obtained from all participants or their next of kin. All 
patients were referred to Sahlgrenska University Hospital during the period June 2006 – 
September 2009 and had sustained TBI. Patients were included based on the criteria that a 
suspicion of DAI was raised due to affected consciousness and/or focal neurological 
symptoms without an obvious explanation seen on the computerized tomography (CT) scan of 
the brain. On admission, the initial level of consciousness was assessed using the Reaction 
Level Scale (RLS).9 The RLS can be translated to the Glasgow Coma Scale (GCS) and the 
translated GCS is presented here.10 The type of trauma was also recorded. 
The extended Glasgow Outcome Scale (GOSE) was used for global evaluation of outcome.11 
The assessment of GOSE scores was based on interviews with the patients or their next of kin 
by a nurse at 12 months postinjury. 
The first MRI was performed within 9 days (range 4-9 days) postinjury and sequences 
including T1, T2, T2* and FLAIR were analysed by a radiologist (MM) and the presence of 
signs of DAI were classified according to Adams et al.12 The follow-up MRI was performed 
at 12 months postinjury and for these examinations the DTI parameters were analysed. MR-
DTI was performed on a Philips Gyroscan Intera 1.5 T, release 9. The DTI method used was 
HARDI (high angular resolution diffusion imaging; Philips, Eindhoven, the Netherlands). For 
the DTI analysis the corpus callosum was chosen for study in this investigation as it is prone 
to DAI12 and it is anatomically easy to define using MR-DTI. Fiber tracking was performed 
using the fiber assignment by continuous tracking (FACT) algorithm in DTIStudio V 2.4 
(Johns Hopkins Medical Institute, Laboratory of Brain Anatomical MRI, 
http://lbam.med.jhmi.edu/).13 From the data provided in DTIStudio, we extracted FA and 
trace for the tracked voxels in the mid-sagittal section of the whole corpus callosum. Data was 
 analysed for 7 patients at 12 months postinjury as well as for 16 healthy, age-matched 
controls. The technique for DTI acquisition and data analysis has been described in detail 
elsewhere.14 
Blood samples from the patients were obtained within six days postinjury as well as from 22 
healthy age-matched controls. Serum NFL concentrations were measured using an 
ultrasensitive Simoa assay as previously described.15 S100B concentrations were measured on 
the Cobas e601 instrument using the Elecsys S100 test (Roche Diagnostics, Mannheim, 
Germany). 
 
The results are expressed as mean ± standard deviation. Age in the patient group and the 
control group was compared using a t-test, NFL concentrations were compared using the 
Mann-Whitney U-test, and DTI-parameters were analysed using Fisher’s non-parametric 
permutation test. P < 0.05 was considered significant. The relationship between NFL 
concentrations and DTI parameters was explored using simple linear regression, and the 
goodness of fit is presented as R2. 
  
 
 
 
 
 
 
 
 
Results  
Nine patients, 7 men and 2 women, were included. The mean age of the patients was 40.4 
years (range 19-69 years). The initial GCS scores of the patients ranged from 3 to 14. None of 
the patients had any intracranial mass lesions requiring evacuation that could explain their 
loss of consciousness. 
One patient died and the outcomes of the surviving patients, measured by the GOSE at 12 
months, ranged from 3 to 6. In summary, five patients had a severe disability and three 
patients a moderate severity. Using conventional MRI in the acute stage, all patients had signs 
of DAI, with a majority of patients classified as Adams’ 2-3 and displaying signs of axonal 
injury in the hemispheres, the corpus callosum as well as in the brain stem. Clinical 
characteristics and the outcome scores of the patients are presented in table 1.     
[Insert Table 1 about here] 
Serum NFL concentrations of the patients ranged from 87.5 to 851.6 pg/ml and were 
markedly higher than serum levels in controls (10.8 ±5.4; Figure 1). Serum S100B 
concentrations of the patients ranged from 0.03 to 0.10 µg/L (reference value <0.10 µg/L). 
 [Insert Figure 1 about here] 
For seven patients, it was possible to analyse the MR-DTI performed at 12 months (two 
examinations were missing since one patient died and one examination was lost due to 
technical problems). For the diffusion parameters, a significant reduction in FA in the corpus 
callosum was seen compared to the controls (0.51 ±0.07 vs. 0.62 ±0.04) and a significant 
increase in trace (2.87 ±0.34 vs. 2.28 ±0.12).  
When dichotomizing the patients into two groups based on their outcome at 12 months, five 
patients had a severe disability (GOSE 3-4) and three patients a moderate severity (GOSE 5-
6). The mean serum NFL concentration in the patients with severe disability was 411 ±263 
and in the patients with a moderate severity it was 277 ±80. The difference was not 
significant. 
When plotting the acute serum NFL concentrations versus the DTI parameters at 12 months 
postinjury we found a linear relationship. A positive relation was found between trace and the 
serum NFL (R2=0.79) and negative relation between the FA and the serum NFL (R2=0.70; 
Figure 2). 
[Insert Figure 2 about here] 
 
 
 
 
 
 
 
 
 Discussion 
In the present prospective longitudinal study we have examined a novel biomarker, serum 
NFL, in a cohort of patients with DAI. The acute serum NFL concentrations were 
significantly higher for patients compared to controls, and we found a correlation between the 
increased NFL concentrations and affected MR-DTI parameters at 12 months postinjury. 
S100B concentrations were not significantly increased for the patients, but the blood samples 
were taken 4-9 days postinjury, and it is possible that S100B could have normalized. 
  
cerebrospinal fluid (CSF) NFL is a well-established biomarker for axonal injury and clearly 
elevated concentrations are seen in patients with cerebrovascular insults and mild to severe 
traumatic brain injury.16,17 However, an obvious limitation of CSF NFL is the requirement for 
lumbar puncture. For this reason, a sensitive and reliable blood biomarker of CNS injury 
would be preferred. Recent developments in ultrasensitive measurement techniques have 
allowed us to establish a sensitive and specific NFL assay for serum and plasma 
measurements15,18 and we have shown that serum/plasma NFL correlates with CSF NFL with 
a correlation coefficient of 0.89.15   
In the current study we used this NFL assay on a cohort of TBI patients with a clinical 
suspicion of DAI, due to loss of consciousness that could not be explained by CT findings and 
signs of DAI classified as Adams’ grade 2-3 on the acute MRI. The outcomes at 12 months 
with GOSE scores ranging from 1 to 6 indicate that the patients were severely injured.  
 
We found that the mean NFL concentrations among the patients displayed a 30-fold increase 
compared to the controls and that NFL concentrations completely discriminated between the 
patients and the controls. However, while it is likely that the increase in NFL is caused by 
DAI, it is also possible that axonal injury due to hypoxic ischemic change and/or swelling 
 might be reflected by the marker. Although the number of patients in our study is small our 
result indicates that NFL may be a useable biomarker of TBI.  
A recent study showed that measurement of another axonal protein, microtubule-associated 
protein tau, in interstitial fluid collected by microdialysis catheters correlates with DTI 
measurements.19 However, not only does collection of interstitial fluid require craniotomy, 
but tau protein also seems to be a less sensitive biomarker for mild TBI than NFL.20,21 In the 
present study, we analysed NFL in blood samples and found a relation between the increased 
serum concentration and the DTI parameters. A number of studies have shown a relationship 
between the severity of TBI, affected DTI parameters and clinical outcome. TBI, and 
especially DAI, reduces FA and increases trace, and the affected DTI parameters correlate to 
clinical outcome.7,14 The positive relation between NFL and trace, and the negative relation 
between NFL and FA, indicate that serum NFL might be an indicator of the severity of the 
DAI.  
We currently plan studies with larger number of patients to further investigate the possible 
role of serum NFL as a valuable biomarker in TBI. Further studies will show if NFL also is 
increased in patients with mild TBI, if it is specifically sensitive to DAI and if it is directly 
correlated to outcome.  
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